Dose‐ranging efficacy and safety study of ertugliflozin, a sodium‐glucose co‐transporter 2 inhibitor, in patients with type 2 diabetes on a background of metformin

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 6, 2015-06 ,pp. : 591-598

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of 12-Week Tai Chi Chuan Exercise on Peripheral Nerve Modulation in Patients with Type 2 Diabetes Mellitus

By Hung Jen-Wen   Liou Chia-Wei   Wang Pei-Wen   Yeh Shu-Hui   Lin Li-Wei   Lo Sing-Kai   Tsai Fu-Mian  

Journal of Rehabilitation Medicine, Vol. 41, Iss. 11, 2009-10 ,pp. : 924-929

Medical Journals Limited

Access to resources Recommend Favorite

Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study

By Seino Yutaka   Fujita Tetsuya   Hiroi Shinzo   Hirayama Masashi   Kaku Kohei  

Current Medical Research and Opinion, Vol. 27, Iss. 9, 2011-09 ,pp. : 1781-1792

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of the Chinese herbal medicine Jinlida in type 2 diabetes patients based on stratification: Results of subgroup analysis from a 12‐week trial

By  

JOURNAL OF DIABETES, Vol. 10, Iss. 2, 2018-02 ,pp. : 112-120

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of bombesin receptor subtype-3 and its synthetic agonist on signaling, glucose transport and metabolism in myocytes from patients with obesity and type 2 diabetes

By              

International Journal of Molecular Medicine, Vol. 35, Iss. 4, 2015-01 ,pp. : 925-931

Spandidos Publications

Access to resources Recommend Favorite